Glucose lowering effect of transgenic human insulin-like growth factor-I from rice: in vitro and in vivo studies
2011

Glucose Lowering Effect of Transgenic Human Insulin-like Growth Factor-I from Rice

Sample size: 21 publication Evidence: moderate

Author Information

Author(s): Cheung Stanley CK, Liu Li-zhong, Lan Lin-lin, Liu Qiao-quan, Sun Samuel SM, Chan Juliana CN, Tong Peter CY

Primary Institution: The Chinese University of Hong Kong

Hypothesis

Functional rhIGF-I could be produced in transgenic rice grains.

Conclusion

Biologically active rhIGF-I can be produced in transgenic rice, which effectively reduces blood glucose levels in diabetic rats.

Supporting Evidence

  • One gram of SI rice grain had the maximum activity level equivalent to 3.2 μM of commercial rhIGF-I.
  • Rice-derived rhIGF-I induced membrane ruffling and enhanced glucose uptake in rat skeletal muscle cells.
  • Oral administration of transgenic rhIGF-I rice reduced plasma glucose levels in diabetic rats.

Takeaway

Scientists made rice that can produce a special protein that helps lower blood sugar, which could help people with diabetes.

Methodology

Transgenic rice was created using Agrobacterium-mediated transformation to express rhIGF-I, followed by in vitro and in vivo testing for glucose uptake and blood glucose levels.

Limitations

The study is preliminary and only tested the acute effects of rhIGF-I; long-term effects and purification for clinical use were not addressed.

Participant Demographics

Streptozotocin-induced diabetic rats and Zucker diabetic fatty rats were used for in vivo studies.

Statistical Information

P-Value

0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1472-6750-11-37

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication